Aminophenols
Aobchem 4-Bromo-2 6-difluoro-N N-dimethylbenzamide | ≥97% | CAS 1515527-94-2 | C9H8BrF2NO | 5g
4-Bromo-2 6-difluoro-N N-dimethylbenzamide | ≥97% | CAS 1515527-94-2 | C9H8BrF2NO | 5g
Aobchem 1-Bromo-2 3-difluoro-4 5-dimethoxybenzene | 95% | C8H7BrF2O2 | 500mg
1-Bromo-2 3-difluoro-4 5-dimethoxybenzene | 95% | C8H7BrF2O2 | 500mg
Aobchem 2 4-Dibromo-1-chloro-3 5-dimethylbenzene | 95% | CAS 2969485-46-7 | C8H7Br2Cl | 500mg
2 4-Dibromo-1-chloro-3 5-dimethylbenzene | 95% | CAS 2969485-46-7 | C8H7Br2Cl | 500mg
Aobchem 5-Bromo-N-cyclohexyl-2 4-dimethylbenzamide | ≥97% | CAS 2643367-43-3 | C15H20BrNO | 250mg
5-Bromo-N-cyclohexyl-2 4-dimethylbenzamide | ≥97% | CAS 2643367-43-3 | C15H20BrNO | 250mg
Aobchem 2-Chloro-1-(4-ethoxy-3 5-dimethylphenyl)-2 2-difluoroethanone | 97% | CAS 3002515-12-7 | C12H13ClF2O2 | 1g
2-Chloro-1-(4-ethoxy-3 5-dimethylphenyl)-2 2-difluoroethanone | 97% | CAS 3002515-12-7 | C12H13ClF2O2 | 1g
Aobchem 3-Bromo-N-cyclohexyl-2 6-dimethoxybenzamide | 97% | CAS 2755716-49-3 | C15H20BrNO3 | 5g
3-Bromo-N-cyclohexyl-2 6-dimethoxybenzamide | 97% | CAS 2755716-49-3 | C15H20BrNO3 | 5g
Aobchem 2-Bromo-N-(2-hydroxy-1 1-dimethylethyl)benzamide | ≥95% | CAS 54596-21-3 | C11H14BrNO2 | 5g
2-Bromo-N-(2-hydroxy-1 1-dimethylethyl)benzamide | ≥95% | CAS 54596-21-3 | C11H14BrNO2 | 5g
TARGETMOL CHEMICALS INC DBET6 10MG
Also available in 1 mg 5 mg 25 mg 50 mg 100 mg 200 mg 500 mg 1 mL 10 mM (in DMSO) and bulk. Please contact Fisher for quotes. dBET6 is a selective and cell-permeable degrader of BET based on PROTAC (IC50 14 nM). It has antitumor activity. purity: 99%
TARGETMOL CHEMICALS INC MKC-1 5MG
Also available in 1 mg 10 mg 25 mg 50 mg 100 mg 500 mg 1 mL 10 mM (in DMSO) and bulk. Please contact Fisher for quotes. MKC-1 (Ro-31-7453) is an orally bioavailable small-molecule bisindolylmaleimide cell cycle inhibitor with potential antineoplastic activity. MKC-1 and its metabolites inhibit tubulin polymerization blocking the formation of the mitotic spindle which may result inpurity: 99%
Aobchem 3-Bromo-2 4-difluoro-1 5-dimethoxybenzene | ≥97% | CAS 1700265-02-6 | C8H7BrF2O2 | 5g
3-Bromo-2 4-difluoro-1 5-dimethoxybenzene | ≥97% | CAS 1700265-02-6 | C8H7BrF2O2 | 5g
Medchemexpress LLC MOG (35-55), human | 163158-19-8 | 98.9% | 2591.99 | 1 MG
MOG (35-55), human is a component of CNS myelin. It differs from mMOG (35-55) by a proline for serine substitution at position 42. This peptide is immunogenic via binding to H-2b class II MHC and is recognized by T cells, but it is not encephalitogenic. It shows only partial cross-reactivity with mMOG35-55 and induces minimal clinical signs of EAE compared to the rodent peptide.
- Component of CNS myelin.
- Immunogenic via binding to H-2b class II MHC.
- Recognized by T cells.
- Induces minimal clinical signs of EAE relative to the rodent peptide.
- Not encephalitogenic.
- Partially cross-reactive with mMOG35-55.
eMolecules 76045-71-1 | 3-Amino-5-hydroxybenzoic acid | Combi-Blocks | MFCD06797571 | 153.137 | C7H7NO3 | 95.000 | Nc1cc(O)cc(c1)C(O)=O | 1g | 205413561
3-Amino-5-hydroxybenzoic acid | Combi-Blocks | 76045-71-1 | MFCD06797571 | 153.137 | C7H7NO3 | 95.000 | Nc1cc(O)cc(c1)C(O)=O | 1g | 205413561
